Skip to main content
. 2014 Jan 20;17(1):15–23. [Article in Chinese] doi: 10.3779/j.issn.1009-3419.2014.01.03

4.

单因素分析影响老年广泛期SCLC患者生存期的相关因素

Single analysis for survival of the ED-SCLC in the elderly

Factor n (%) MST (month) 95%CI (month) P
Total 115 11 9.6-12.4
Sex Male 85 (73.9) 9 7.2-10.8 0.002
Female 30 (26.1) 16 11.0-21.0
Age (yr) 65-75 98 (85.2) 11 9.6-12.4 0.155
≥75 17 (14.8) 8 5.6-10.4
PS before treatment (ECOG) 0 4 (3.5) 10 3.1-16.9 0.523
1 82 (71.3) 10 7.7-12.3
2 23 (20.2) 11 10.2-11.8
3 6 (5.2) 8 3.2-12.8
The change of PS after treatment Improve 56 (48.7) 11 9.1-12.9 <0.001
Stable 41 (35.7) 12 9.9-14.1
Worsen 18 (15.6) 4 3.0-5.0
Chemotherapy scheme EP or EC 94 (81.7) 11 9.6-12.4 0.007
Not EP or EC 21 (18.3) 8 5.3-10.7
Liver Yes 29 (25.2) 7 5.0-9.0 0.001
No 86 (74.8) 12 10.1-13.9
Lung Yes 40 (34.8) 10 8.3-11.7 0.396
No 75 (65.2) 11 9.1-12.9
Brain Yes 24 (20.9) 8 6.1-9.9 0.063
No 91 (79.1) 11 9.6-12.4
Abdomen Yes 32 (27.8) 10 7.8-12.2 0.073
No 83 (72.2) 11 8.9-13.1
Bone Yes 28 (24.3) 9 6.4-11.6 0.087
No 87 (75.7) 11 9.5-12.5
Radiotherapy Yes 50 (56.8) 14 10.7-17.3 < 0.001
No 38 (43.2) 10 8.1-11.9
Radiotherapy
(< 2 organ metastasis)
Yes
No
40 (66.7)
20 (33.3)
16
8
12.7-19.3
5.8-10.2
< 0.001
Radiotherapy
(≥2 organ metastasis)
Yes
No
10 (35.7)
18 (64.3)
9
11
7.5-10.5
10.1-12.0
0.891
PCI Yes 12 (24.0) 23 16.6-29.4 0.01
No 38 (76.0) 12 10.7-13.3